pvgi.1 (vegf-2)
Gene therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2004 (NCT00090714)
Timeline
Indications
Mechanism of action
- Vascular endothelial growth factor CSupplementation
VEGFC supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pvgi.1 (vegf-2)
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00304837 | Phase 1 | Mar 16, 2006 | Northwestern University |
| NCT00090714 | Phase 2 | Aug 1, 2004 | Corautus Genetics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Corautus Genetics | For profit | 1 | 1 | 1 | 2004 |
| Northwestern University | Academic/Hospital | 1 | 1 | 1 | 2006 |
2 organizations
Page 1 / 1